Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. VVOS Peers
See (VVOS) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VVOS | $6.82 | +2.25% | 41.5M | -6.77 | -$1.04 | N/A |
| ABT | $132.02 | -1.18% | 229.6B | 17.16 | $7.69 | +1.73% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $103.20 | -0.64% | 152.7B | 75.32 | $1.37 | N/A |
| SYK | $389.46 | -1.35% | 148.8B | 52.63 | $7.40 | +0.85% |
| MDT | $89.92 | +0.58% | 115.2B | 24.91 | $3.61 | +3.90% |
| EW | $78.05 | -0.95% | 45.8B | 32.25 | $2.42 | N/A |
| DXCM | $83.37 | -2.45% | 32.7B | 62.69 | $1.33 | N/A |
| STE | $228.03 | -1.17% | 22.4B | 37.01 | $6.16 | +1.23% |
| PHG | $24.03 | -2.53% | 22.2B | 77.48 | $0.31 | +3.68% |
Stock Comparison
VVOS vs ABT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ABT has a market cap of 229.6B. Regarding current trading prices, VVOS is priced at $6.82, while ABT trades at $132.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ABT's P/E ratio is 17.16. In terms of profitability, VVOS's ROE is -1.70%, compared to ABT's ROE of +0.31%. Regarding short-term risk, VVOS is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BSX-PA Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, VVOS is priced at $6.82, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, VVOS's ROE is -1.70%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, VVOS is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BSX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BSX has a market cap of 152.7B. Regarding current trading prices, VVOS is priced at $6.82, while BSX trades at $103.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BSX's P/E ratio is 75.32. In terms of profitability, VVOS's ROE is -1.70%, compared to BSX's ROE of +0.10%. Regarding short-term risk, VVOS is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SYK Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SYK has a market cap of 148.8B. Regarding current trading prices, VVOS is priced at $6.82, while SYK trades at $389.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SYK's P/E ratio is 52.63. In terms of profitability, VVOS's ROE is -1.70%, compared to SYK's ROE of +0.11%. Regarding short-term risk, VVOS is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs MDT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, MDT has a market cap of 115.2B. Regarding current trading prices, VVOS is priced at $6.82, while MDT trades at $89.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas MDT's P/E ratio is 24.91. In terms of profitability, VVOS's ROE is -1.70%, compared to MDT's ROE of +0.10%. Regarding short-term risk, VVOS is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs EW Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, EW has a market cap of 45.8B. Regarding current trading prices, VVOS is priced at $6.82, while EW trades at $78.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas EW's P/E ratio is 32.25. In terms of profitability, VVOS's ROE is -1.70%, compared to EW's ROE of +0.49%. Regarding short-term risk, VVOS is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs DXCM Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, VVOS is priced at $6.82, while DXCM trades at $83.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas DXCM's P/E ratio is 62.69. In terms of profitability, VVOS's ROE is -1.70%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, VVOS is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs STE Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, STE has a market cap of 22.4B. Regarding current trading prices, VVOS is priced at $6.82, while STE trades at $228.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas STE's P/E ratio is 37.01. In terms of profitability, VVOS's ROE is -1.70%, compared to STE's ROE of +0.09%. Regarding short-term risk, VVOS is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PHG Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PHG has a market cap of 22.2B. Regarding current trading prices, VVOS is priced at $6.82, while PHG trades at $24.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PHG's P/E ratio is 77.48. In terms of profitability, VVOS's ROE is -1.70%, compared to PHG's ROE of +0.03%. Regarding short-term risk, VVOS is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PODD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PODD has a market cap of 20.4B. Regarding current trading prices, VVOS is priced at $6.82, while PODD trades at $289.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PODD's P/E ratio is 52.71. In terms of profitability, VVOS's ROE is -1.70%, compared to PODD's ROE of +0.35%. Regarding short-term risk, VVOS is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ZBH Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ZBH has a market cap of 18.6B. Regarding current trading prices, VVOS is priced at $6.82, while ZBH trades at $93.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ZBH's P/E ratio is 20.84. In terms of profitability, VVOS's ROE is -1.70%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, VVOS is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ABMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, VVOS is priced at $6.82, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ABMD's P/E ratio is 65.36. In terms of profitability, VVOS's ROE is -1.70%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, VVOS is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ALGN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ALGN has a market cap of 14.7B. Regarding current trading prices, VVOS is priced at $6.82, while ALGN trades at $202.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ALGN's P/E ratio is 36.84. In terms of profitability, VVOS's ROE is -1.70%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, VVOS is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SNN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SNN has a market cap of 13.2B. Regarding current trading prices, VVOS is priced at $6.82, while SNN trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SNN's P/E ratio is 32.21. In terms of profitability, VVOS's ROE is -1.70%, compared to SNN's ROE of +0.08%. Regarding short-term risk, VVOS is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SWAV Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, VVOS is priced at $6.82, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SWAV's P/E ratio is 78.76. In terms of profitability, VVOS's ROE is -1.70%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, VVOS is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PEN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PEN has a market cap of 9.2B. Regarding current trading prices, VVOS is priced at $6.82, while PEN trades at $237.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PEN's P/E ratio is 220.28. In terms of profitability, VVOS's ROE is -1.70%, compared to PEN's ROE of +0.04%. Regarding short-term risk, VVOS is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs GMED Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, GMED has a market cap of 7.7B. Regarding current trading prices, VVOS is priced at $6.82, while GMED trades at $57.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas GMED's P/E ratio is 42.29. In terms of profitability, VVOS's ROE is -1.70%, compared to GMED's ROE of +0.05%. Regarding short-term risk, VVOS is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BIO-B Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BIO-B has a market cap of 7B. Regarding current trading prices, VVOS is priced at $6.82, while BIO-B trades at $257.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BIO-B's P/E ratio is -3.37. In terms of profitability, VVOS's ROE is -1.70%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, VVOS is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BIO Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BIO has a market cap of 7B. Regarding current trading prices, VVOS is priced at $6.82, while BIO trades at $256.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BIO's P/E ratio is -3.36. In terms of profitability, VVOS's ROE is -1.70%, compared to BIO's ROE of -0.32%. Regarding short-term risk, VVOS is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BRKR Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BRKR has a market cap of 6.6B. Regarding current trading prices, VVOS is priced at $6.82, while BRKR trades at $43.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BRKR's P/E ratio is 84.21. In terms of profitability, VVOS's ROE is -1.70%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, VVOS is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs GKOS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, GKOS has a market cap of 5.9B. Regarding current trading prices, VVOS is priced at $6.82, while GKOS trades at $103.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas GKOS's P/E ratio is -45.70. In terms of profitability, VVOS's ROE is -1.70%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, VVOS is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs NARI Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, VVOS is priced at $6.82, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas NARI's P/E ratio is -59.24. In terms of profitability, VVOS's ROE is -1.70%, compared to NARI's ROE of -0.18%. Regarding short-term risk, VVOS is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs IRTC Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, IRTC has a market cap of 4.3B. Regarding current trading prices, VVOS is priced at $6.82, while IRTC trades at $135.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas IRTC's P/E ratio is -43.27. In terms of profitability, VVOS's ROE is -1.70%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, VVOS is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ITGR Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, VVOS is priced at $6.82, while ITGR trades at $119.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ITGR's P/E ratio is 56.02. In terms of profitability, VVOS's ROE is -1.70%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, VVOS is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs INSP Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, INSP has a market cap of 3.8B. Regarding current trading prices, VVOS is priced at $6.82, while INSP trades at $130.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas INSP's P/E ratio is 59.75. In terms of profitability, VVOS's ROE is -1.70%, compared to INSP's ROE of +0.10%. Regarding short-term risk, VVOS is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs TMDX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, TMDX has a market cap of 3.8B. Regarding current trading prices, VVOS is priced at $6.82, while TMDX trades at $112.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas TMDX's P/E ratio is 79.20. In terms of profitability, VVOS's ROE is -1.70%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, VVOS is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs AXNX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, VVOS is priced at $6.82, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas AXNX's P/E ratio is -709.80. In terms of profitability, VVOS's ROE is -1.70%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, VVOS is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PRCT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PRCT has a market cap of 3.1B. Regarding current trading prices, VVOS is priced at $6.82, while PRCT trades at $56.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PRCT's P/E ratio is -33.52. In terms of profitability, VVOS's ROE is -1.70%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, VVOS is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs LIVN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, LIVN has a market cap of 2.4B. Regarding current trading prices, VVOS is priced at $6.82, while LIVN trades at $44.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas LIVN's P/E ratio is -10.89. In terms of profitability, VVOS's ROE is -1.70%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, VVOS is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs NUVA Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, VVOS is priced at $6.82, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas NUVA's P/E ratio is 75.00. In terms of profitability, VVOS's ROE is -1.70%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, VVOS is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs UFPT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, VVOS is priced at $6.82, while UFPT trades at $242.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas UFPT's P/E ratio is 29.72. In terms of profitability, VVOS's ROE is -1.70%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, VVOS is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ATEC Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, VVOS is priced at $6.82, while ATEC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ATEC's P/E ratio is -9.64. In terms of profitability, VVOS's ROE is -1.70%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, VVOS is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CNMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CNMD has a market cap of 1.6B. Regarding current trading prices, VVOS is priced at $6.82, while CNMD trades at $51.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CNMD's P/E ratio is 13.45. In terms of profitability, VVOS's ROE is -1.70%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, VVOS is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs AORT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, VVOS is priced at $6.82, while AORT trades at $31.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas AORT's P/E ratio is -61.75. In terms of profitability, VVOS's ROE is -1.70%, compared to AORT's ROE of -0.07%. Regarding short-term risk, VVOS is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs HSKA Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, VVOS is priced at $6.82, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas HSKA's P/E ratio is -62.49. In terms of profitability, VVOS's ROE is -1.70%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, VVOS is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ESTA Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ESTA has a market cap of 1.3B. Regarding current trading prices, VVOS is priced at $6.82, while ESTA trades at $44.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ESTA's P/E ratio is -14.37. In terms of profitability, VVOS's ROE is -1.70%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, VVOS is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs AHCO Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, AHCO has a market cap of 1.2B. Regarding current trading prices, VVOS is priced at $6.82, while AHCO trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas AHCO's P/E ratio is 15.90. In terms of profitability, VVOS's ROE is -1.70%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, VVOS is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SILK Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, VVOS is priced at $6.82, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SILK's P/E ratio is -18.96. In terms of profitability, VVOS's ROE is -1.70%, compared to SILK's ROE of -0.29%. Regarding short-term risk, VVOS is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs FNA Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, VVOS is priced at $6.82, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas FNA's P/E ratio is -19.83. In terms of profitability, VVOS's ROE is -1.70%, compared to FNA's ROE of -0.36%. Regarding short-term risk, VVOS is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs TNDM Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, TNDM has a market cap of 1B. Regarding current trading prices, VVOS is priced at $6.82, while TNDM trades at $15.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas TNDM's P/E ratio is -5.59. In terms of profitability, VVOS's ROE is -1.70%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, VVOS is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs INMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, INMD has a market cap of 1B. Regarding current trading prices, VVOS is priced at $6.82, while INMD trades at $14.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas INMD's P/E ratio is 6.60. In terms of profitability, VVOS's ROE is -1.70%, compared to INMD's ROE of +0.25%. Regarding short-term risk, VVOS is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs IART Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, IART has a market cap of 977.6M. Regarding current trading prices, VVOS is priced at $6.82, while IART trades at $12.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas IART's P/E ratio is -33.11. In terms of profitability, VVOS's ROE is -1.70%, compared to IART's ROE of -0.03%. Regarding short-term risk, VVOS is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SSII Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SSII has a market cap of 947.3M. Regarding current trading prices, VVOS is priced at $6.82, while SSII trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SSII's P/E ratio is -61.16. In terms of profitability, VVOS's ROE is -1.70%, compared to SSII's ROE of -1.05%. Regarding short-term risk, VVOS is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CSII Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, VVOS is priced at $6.82, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CSII's P/E ratio is -20.83. In terms of profitability, VVOS's ROE is -1.70%, compared to CSII's ROE of -0.14%. Regarding short-term risk, VVOS is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SIBN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SIBN has a market cap of 732.1M. Regarding current trading prices, VVOS is priced at $6.82, while SIBN trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SIBN's P/E ratio is -27.27. In terms of profitability, VVOS's ROE is -1.70%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, VVOS is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs IRMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, IRMD has a market cap of 731.5M. Regarding current trading prices, VVOS is priced at $6.82, while IRMD trades at $57.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas IRMD's P/E ratio is 37.12. In terms of profitability, VVOS's ROE is -1.70%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, VVOS is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CRY Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, VVOS is priced at $6.82, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CRY's P/E ratio is 425.71. In terms of profitability, VVOS's ROE is -1.70%, compared to CRY's ROE of -0.07%. Regarding short-term risk, VVOS is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CBLL Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CBLL has a market cap of 583.2M. Regarding current trading prices, VVOS is priced at $6.82, while CBLL trades at $16.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CBLL's P/E ratio is -12.91. In terms of profitability, VVOS's ROE is -1.70%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, VVOS is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs APEN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, VVOS is priced at $6.82, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas APEN's P/E ratio is -9.43. In terms of profitability, VVOS's ROE is -1.70%, compared to APEN's ROE of -0.85%. Regarding short-term risk, VVOS is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs AVNS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, AVNS has a market cap of 552.2M. Regarding current trading prices, VVOS is priced at $6.82, while AVNS trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas AVNS's P/E ratio is -1.44. In terms of profitability, VVOS's ROE is -1.70%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, VVOS is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs KIDS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, KIDS has a market cap of 543.7M. Regarding current trading prices, VVOS is priced at $6.82, while KIDS trades at $21.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas KIDS's P/E ratio is -12.47. In terms of profitability, VVOS's ROE is -1.70%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, VVOS is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs AXGN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, AXGN has a market cap of 542M. Regarding current trading prices, VVOS is priced at $6.82, while AXGN trades at $11.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas AXGN's P/E ratio is -74.37. In terms of profitability, VVOS's ROE is -1.70%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, VVOS is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SMLR Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SMLR has a market cap of 507.5M. Regarding current trading prices, VVOS is priced at $6.82, while SMLR trades at $45.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SMLR's P/E ratio is -19.04. In terms of profitability, VVOS's ROE is -1.70%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, VVOS is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BFLY-WT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BFLY-WT has a market cap of 474M. Regarding current trading prices, VVOS is priced at $6.82, while BFLY-WT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, VVOS's ROE is -1.70%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, VVOS is more volatile compared to BFLY-WT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BVS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BVS has a market cap of 461.8M. Regarding current trading prices, VVOS is priced at $6.82, while BVS trades at $6.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BVS's P/E ratio is -14.50. In terms of profitability, VVOS's ROE is -1.70%, compared to BVS's ROE of -0.21%. Regarding short-term risk, VVOS is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BFLY Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BFLY has a market cap of 447.6M. Regarding current trading prices, VVOS is priced at $6.82, while BFLY trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BFLY's P/E ratio is -6.03. In terms of profitability, VVOS's ROE is -1.70%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, VVOS is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SRDX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SRDX has a market cap of 441.4M. Regarding current trading prices, VVOS is priced at $6.82, while SRDX trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SRDX's P/E ratio is -22.05. In terms of profitability, VVOS's ROE is -1.70%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, VVOS is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PACB Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PACB has a market cap of 441.1M. Regarding current trading prices, VVOS is priced at $6.82, while PACB trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PACB's P/E ratio is -0.52. In terms of profitability, VVOS's ROE is -1.70%, compared to PACB's ROE of -1.70%. Regarding short-term risk, VVOS is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CTKB Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CTKB has a market cap of 436.3M. Regarding current trading prices, VVOS is priced at $6.82, while CTKB trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CTKB's P/E ratio is -38.28. In terms of profitability, VVOS's ROE is -1.70%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, VVOS is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs OFIX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, OFIX has a market cap of 432.6M. Regarding current trading prices, VVOS is priced at $6.82, while OFIX trades at $11.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas OFIX's P/E ratio is -2.98. In terms of profitability, VVOS's ROE is -1.70%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, VVOS is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs TMCI Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, TMCI has a market cap of 377.4M. Regarding current trading prices, VVOS is priced at $6.82, while TMCI trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas TMCI's P/E ratio is -7.06. In terms of profitability, VVOS's ROE is -1.70%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, VVOS is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SENS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SENS has a market cap of 373M. Regarding current trading prices, VVOS is priced at $6.82, while SENS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SENS's P/E ratio is -4.50. In terms of profitability, VVOS's ROE is -1.70%, compared to SENS's ROE of -7.46%. Regarding short-term risk, VVOS is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs OM Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, OM has a market cap of 346.6M. Regarding current trading prices, VVOS is priced at $6.82, while OM trades at $19.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas OM's P/E ratio is -0.68. In terms of profitability, VVOS's ROE is -1.70%, compared to OM's ROE of -1.45%. Regarding short-term risk, VVOS is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs VREX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, VREX has a market cap of 339.1M. Regarding current trading prices, VVOS is priced at $6.82, while VREX trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas VREX's P/E ratio is -7.93. In terms of profitability, VVOS's ROE is -1.70%, compared to VREX's ROE of -0.08%. Regarding short-term risk, VVOS is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs RXST Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, RXST has a market cap of 325.3M. Regarding current trading prices, VVOS is priced at $6.82, while RXST trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas RXST's P/E ratio is -12.13. In terms of profitability, VVOS's ROE is -1.70%, compared to RXST's ROE of -0.10%. Regarding short-term risk, VVOS is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs NNOX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, NNOX has a market cap of 323M. Regarding current trading prices, VVOS is priced at $6.82, while NNOX trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas NNOX's P/E ratio is -5.57. In terms of profitability, VVOS's ROE is -1.70%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, VVOS is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CLPT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CLPT has a market cap of 322.2M. Regarding current trading prices, VVOS is priced at $6.82, while CLPT trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CLPT's P/E ratio is -15.00. In terms of profitability, VVOS's ROE is -1.70%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, VVOS is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs NPCE Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, NPCE has a market cap of 311.9M. Regarding current trading prices, VVOS is priced at $6.82, while NPCE trades at $9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas NPCE's P/E ratio is -11.60. In terms of profitability, VVOS's ROE is -1.70%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, VVOS is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PTHL Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PTHL has a market cap of 300M. Regarding current trading prices, VVOS is priced at $6.82, while PTHL trades at $21.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PTHL's P/E ratio is -421.00. In terms of profitability, VVOS's ROE is -1.70%, compared to PTHL's ROE of -0.30%. Regarding short-term risk, VVOS is more volatile compared to PTHL. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SNWV Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SNWV has a market cap of 298.2M. Regarding current trading prices, VVOS is priced at $6.82, while SNWV trades at $34.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SNWV's P/E ratio is -5.60. In terms of profitability, VVOS's ROE is -1.70%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, VVOS is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CATX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CATX has a market cap of 295.4M. Regarding current trading prices, VVOS is priced at $6.82, while CATX trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CATX's P/E ratio is -3.24. In terms of profitability, VVOS's ROE is -1.70%, compared to CATX's ROE of -0.27%. Regarding short-term risk, VVOS is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CERS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CERS has a market cap of 278.1M. Regarding current trading prices, VVOS is priced at $6.82, while CERS trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CERS's P/E ratio is -14.55. In terms of profitability, VVOS's ROE is -1.70%, compared to CERS's ROE of -0.35%. Regarding short-term risk, VVOS is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs VMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, VMD has a market cap of 265.6M. Regarding current trading prices, VVOS is priced at $6.82, while VMD trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas VMD's P/E ratio is 21.68. In terms of profitability, VVOS's ROE is -1.70%, compared to VMD's ROE of +0.10%. Regarding short-term risk, VVOS is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ZIMV Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ZIMV has a market cap of 251.3M. Regarding current trading prices, VVOS is priced at $6.82, while ZIMV trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ZIMV's P/E ratio is -9.78. In terms of profitability, VVOS's ROE is -1.70%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, VVOS is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs MASS Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, MASS has a market cap of 248.5M. Regarding current trading prices, VVOS is priced at $6.82, while MASS trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas MASS's P/E ratio is -3.12. In terms of profitability, VVOS's ROE is -1.70%, compared to MASS's ROE of -0.13%. Regarding short-term risk, VVOS is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs MXCT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, MXCT has a market cap of 234.4M. Regarding current trading prices, VVOS is priced at $6.82, while MXCT trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas MXCT's P/E ratio is -5.51. In terms of profitability, VVOS's ROE is -1.70%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, VVOS is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BWAY Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BWAY has a market cap of 232.2M. Regarding current trading prices, VVOS is priced at $6.82, while BWAY trades at $12.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BWAY's P/E ratio is 55.86. In terms of profitability, VVOS's ROE is -1.70%, compared to BWAY's ROE of +0.07%. Regarding short-term risk, VVOS is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs TCMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, TCMD has a market cap of 231.8M. Regarding current trading prices, VVOS is priced at $6.82, while TCMD trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas TCMD's P/E ratio is 15.11. In terms of profitability, VVOS's ROE is -1.70%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, VVOS is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs QTRX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, QTRX has a market cap of 228.9M. Regarding current trading prices, VVOS is priced at $6.82, while QTRX trades at $5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas QTRX's P/E ratio is -4.75. In terms of profitability, VVOS's ROE is -1.70%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, VVOS is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs NVRO Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, VVOS is priced at $6.82, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas NVRO's P/E ratio is -1.91. In terms of profitability, VVOS's ROE is -1.70%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, VVOS is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs EYES Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, VVOS is priced at $6.82, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas EYES's P/E ratio is N/A. In terms of profitability, VVOS's ROE is -1.70%, compared to EYES's ROE of -0.26%. Regarding short-term risk, VVOS is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs INGN Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, INGN has a market cap of 186.1M. Regarding current trading prices, VVOS is priced at $6.82, while INGN trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas INGN's P/E ratio is -6.02. In terms of profitability, VVOS's ROE is -1.70%, compared to INGN's ROE of -0.15%. Regarding short-term risk, VVOS is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs TLSI Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, TLSI has a market cap of 185.7M. Regarding current trading prices, VVOS is priced at $6.82, while TLSI trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas TLSI's P/E ratio is -4.45. In terms of profitability, VVOS's ROE is -1.70%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, VVOS is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs CVRX Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, CVRX has a market cap of 177.8M. Regarding current trading prices, VVOS is priced at $6.82, while CVRX trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas CVRX's P/E ratio is -3.19. In terms of profitability, VVOS's ROE is -1.70%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, VVOS is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs PROF Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, PROF has a market cap of 176.7M. Regarding current trading prices, VVOS is priced at $6.82, while PROF trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas PROF's P/E ratio is -4.86. In terms of profitability, VVOS's ROE is -1.70%, compared to PROF's ROE of -0.70%. Regarding short-term risk, VVOS is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs SGHT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, SGHT has a market cap of 176.3M. Regarding current trading prices, VVOS is priced at $6.82, while SGHT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas SGHT's P/E ratio is -3.48. In terms of profitability, VVOS's ROE is -1.70%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, VVOS is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ANIK Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ANIK has a market cap of 162.1M. Regarding current trading prices, VVOS is priced at $6.82, while ANIK trades at $11.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ANIK's P/E ratio is -15.07. In terms of profitability, VVOS's ROE is -1.70%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, VVOS is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ELMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ELMD has a market cap of 160.2M. Regarding current trading prices, VVOS is priced at $6.82, while ELMD trades at $19.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ELMD's P/E ratio is 24.18. In terms of profitability, VVOS's ROE is -1.70%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, VVOS is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs LNSR Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, LNSR has a market cap of 155M. Regarding current trading prices, VVOS is priced at $6.82, while LNSR trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas LNSR's P/E ratio is -2.68. In terms of profitability, VVOS's ROE is -1.70%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, VVOS is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs RCEL Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, RCEL has a market cap of 151.5M. Regarding current trading prices, VVOS is priced at $6.82, while RCEL trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas RCEL's P/E ratio is -2.62. In terms of profitability, VVOS's ROE is -1.70%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, VVOS is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs RPID Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, RPID has a market cap of 147.3M. Regarding current trading prices, VVOS is priced at $6.82, while RPID trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas RPID's P/E ratio is -3.26. In terms of profitability, VVOS's ROE is -1.70%, compared to RPID's ROE of -0.56%. Regarding short-term risk, VVOS is more volatile compared to RPID. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs OWLT Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, OWLT has a market cap of 144.8M. Regarding current trading prices, VVOS is priced at $6.82, while OWLT trades at $8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas OWLT's P/E ratio is -5.62. In terms of profitability, VVOS's ROE is -1.70%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, VVOS is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BSGM Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BSGM has a market cap of 140.8M. Regarding current trading prices, VVOS is priced at $6.82, while BSGM trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BSGM's P/E ratio is -9.74. In terms of profitability, VVOS's ROE is -1.70%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, VVOS is more volatile compared to BSGM. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs LUCD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, LUCD has a market cap of 123.3M. Regarding current trading prices, VVOS is priced at $6.82, while LUCD trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas LUCD's P/E ratio is -0.97. In terms of profitability, VVOS's ROE is -1.70%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, VVOS is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs MGRM Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, MGRM has a market cap of 118.8M. Regarding current trading prices, VVOS is priced at $6.82, while MGRM trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas MGRM's P/E ratio is -6.66. In terms of profitability, VVOS's ROE is -1.70%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, VVOS is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs AVR Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, AVR has a market cap of 118.2M. Regarding current trading prices, VVOS is priced at $6.82, while AVR trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas AVR's P/E ratio is -0.91. In terms of profitability, VVOS's ROE is -1.70%, compared to AVR's ROE of -2.92%. Regarding short-term risk, VVOS is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs BDMD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, BDMD has a market cap of 118.2M. Regarding current trading prices, VVOS is priced at $6.82, while BDMD trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas BDMD's P/E ratio is 6.75. In terms of profitability, VVOS's ROE is -1.70%, compared to BDMD's ROE of +0.32%. Regarding short-term risk, VVOS is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs LUNG Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, LUNG has a market cap of 115.9M. Regarding current trading prices, VVOS is priced at $6.82, while LUNG trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas LUNG's P/E ratio is -2.00. In terms of profitability, VVOS's ROE is -1.70%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, VVOS is more volatile compared to LUNG. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.
VVOS vs ICAD Comparison
VVOS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VVOS stands at 41.5M. In comparison, ICAD has a market cap of 102.6M. Regarding current trading prices, VVOS is priced at $6.82, while ICAD trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VVOS currently has a P/E ratio of -6.77, whereas ICAD's P/E ratio is -19.66. In terms of profitability, VVOS's ROE is -1.70%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, VVOS is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for VVOS.